BIOENSIS’s Drug Combination Platform is specifically designed to help our clients navigate and functionally interpret their data. Our robust methodologies allow for the testing and analysis of interactions by using a powerful suite of tools that includes: Bliss and Isobologram analysis. This enhanced platform provides a wide spectrum of testing conditions with all of our experiments conducted under physiologically relevant conditions and our cellular models emulating in vivo activity.
BIOENSIS’ Drug Combinations assays:
• Flexible testing protocols for drug-drug combination
• Synergy, antagonism and additivity analysis
• Bliss and Isobologram analysis - are provided as well as IC50 and EC50 .
• Over 150 human tumor cell lines available for testing
• Available in 2D and 3D cultures
Please contact us to discuss your study and an up to date list of available cell lines